Short- and longer-term health-care resource utilization and costs associated with acute ischemic stroke

Barbara H Johnson,1 Machaon M Bonafede,1 Crystal Watson2 1Outcomes Research, Truven Health Analytics, Cambridge, MA, USA; 2Health Economics and Outcomes Research, Biogen, Cambridge, MA, USA Objectives: The mean lifetime cost of ischemic stroke is approximately $140,048 in the United States, placing...

Full description

Bibliographic Details
Main Authors: Johnson BH, Bonafede MM, Watson C
Format: Article
Language:English
Published: Dove Medical Press 2016-02-01
Series:ClinicoEconomics and Outcomes Research
Subjects:
Online Access:https://www.dovepress.com/short--and-longer-term-health-care-resource-utilization-and-costs-asso-peer-reviewed-article-CEOR
_version_ 1819125619262226432
author Johnson BH
Bonafede MM
Watson C
author_facet Johnson BH
Bonafede MM
Watson C
author_sort Johnson BH
collection DOAJ
description Barbara H Johnson,1 Machaon M Bonafede,1 Crystal Watson2 1Outcomes Research, Truven Health Analytics, Cambridge, MA, USA; 2Health Economics and Outcomes Research, Biogen, Cambridge, MA, USA Objectives: The mean lifetime cost of ischemic stroke is approximately $140,048 in the United States, placing stroke among the top 10 most costly conditions among Medicare beneficiaries. The objective of this study was to describe the health-care resource utilization and costs in the year following hospitalization for acute ischemic stroke (AIS).Methods: This retrospective claims analysis quantifies utilization and costs following inpatient admission for AIS among the commercially insured and Medicare beneficiaries in the Truven Health databases. Patients who were 18 years or older and continuously enrolled for 12 months before and after an AIS event occurring (index) between January 2009 and December 2012 were identified. Patients with AIS in the year preindex were excluded. Demographic and clinical characteristics were evaluated at admission and in the preindex, respectively. Direct costs, readmissions, and inpatient length of stay (LOS) were described in the year postindex.Results: The eligible populations comprised 20,314 commercially insured patients and 31,037 Medicare beneficiaries. Average all-cause costs were $61,354 and $44,929 (commercial and Medicare, respectively) in the first year after the AIS. Approximately 50%–55% of total 12-month costs were incurred between day 31 and day 365 following the incident AIS. One quarter (24.6%) of commercially insured patients and 38.8% of Medicare beneficiaries were readmitted within 30 days with 16.6% and 71.7% (commercial and Medicare, respectively) of those having a principal diagnosis of AIS. The average AIS-related readmission length of stay was nearly three times that of the initial hospitalization for both commercially insured patients (3.8 vs 10.8 days) and Medicare beneficiaries (4.0 vs 10.8 days).Conclusion: In addition to the substantial costs of the initial hospitalization of an AIS, these costs double within the year following this event. Given the high cost associated with AIS, new interventions reducing either the acute or longer-term burden of AIS are needed. Keywords: acute ischemic stroke, health-care resource utilization, health-care costs, readmissions
first_indexed 2024-12-22T07:43:01Z
format Article
id doaj.art-b3037eb62fda4079a8d29272a0d0edb4
institution Directory Open Access Journal
issn 1178-6981
language English
last_indexed 2024-12-22T07:43:01Z
publishDate 2016-02-01
publisher Dove Medical Press
record_format Article
series ClinicoEconomics and Outcomes Research
spelling doaj.art-b3037eb62fda4079a8d29272a0d0edb42022-12-21T18:33:42ZengDove Medical PressClinicoEconomics and Outcomes Research1178-69812016-02-012016Issue 1536125693Short- and longer-term health-care resource utilization and costs associated with acute ischemic strokeJohnson BHBonafede MMWatson CBarbara H Johnson,1 Machaon M Bonafede,1 Crystal Watson2 1Outcomes Research, Truven Health Analytics, Cambridge, MA, USA; 2Health Economics and Outcomes Research, Biogen, Cambridge, MA, USA Objectives: The mean lifetime cost of ischemic stroke is approximately $140,048 in the United States, placing stroke among the top 10 most costly conditions among Medicare beneficiaries. The objective of this study was to describe the health-care resource utilization and costs in the year following hospitalization for acute ischemic stroke (AIS).Methods: This retrospective claims analysis quantifies utilization and costs following inpatient admission for AIS among the commercially insured and Medicare beneficiaries in the Truven Health databases. Patients who were 18 years or older and continuously enrolled for 12 months before and after an AIS event occurring (index) between January 2009 and December 2012 were identified. Patients with AIS in the year preindex were excluded. Demographic and clinical characteristics were evaluated at admission and in the preindex, respectively. Direct costs, readmissions, and inpatient length of stay (LOS) were described in the year postindex.Results: The eligible populations comprised 20,314 commercially insured patients and 31,037 Medicare beneficiaries. Average all-cause costs were $61,354 and $44,929 (commercial and Medicare, respectively) in the first year after the AIS. Approximately 50%–55% of total 12-month costs were incurred between day 31 and day 365 following the incident AIS. One quarter (24.6%) of commercially insured patients and 38.8% of Medicare beneficiaries were readmitted within 30 days with 16.6% and 71.7% (commercial and Medicare, respectively) of those having a principal diagnosis of AIS. The average AIS-related readmission length of stay was nearly three times that of the initial hospitalization for both commercially insured patients (3.8 vs 10.8 days) and Medicare beneficiaries (4.0 vs 10.8 days).Conclusion: In addition to the substantial costs of the initial hospitalization of an AIS, these costs double within the year following this event. Given the high cost associated with AIS, new interventions reducing either the acute or longer-term burden of AIS are needed. Keywords: acute ischemic stroke, health-care resource utilization, health-care costs, readmissionshttps://www.dovepress.com/short--and-longer-term-health-care-resource-utilization-and-costs-asso-peer-reviewed-article-CEORacute ischemic strokehealthcare resource utilizationhealthcare costsreadmissions
spellingShingle Johnson BH
Bonafede MM
Watson C
Short- and longer-term health-care resource utilization and costs associated with acute ischemic stroke
ClinicoEconomics and Outcomes Research
acute ischemic stroke
healthcare resource utilization
healthcare costs
readmissions
title Short- and longer-term health-care resource utilization and costs associated with acute ischemic stroke
title_full Short- and longer-term health-care resource utilization and costs associated with acute ischemic stroke
title_fullStr Short- and longer-term health-care resource utilization and costs associated with acute ischemic stroke
title_full_unstemmed Short- and longer-term health-care resource utilization and costs associated with acute ischemic stroke
title_short Short- and longer-term health-care resource utilization and costs associated with acute ischemic stroke
title_sort short and longer term health care resource utilization and costs associated with acute ischemic stroke
topic acute ischemic stroke
healthcare resource utilization
healthcare costs
readmissions
url https://www.dovepress.com/short--and-longer-term-health-care-resource-utilization-and-costs-asso-peer-reviewed-article-CEOR
work_keys_str_mv AT johnsonbh shortandlongertermhealthcareresourceutilizationandcostsassociatedwithacuteischemicstroke
AT bonafedemm shortandlongertermhealthcareresourceutilizationandcostsassociatedwithacuteischemicstroke
AT watsonc shortandlongertermhealthcareresourceutilizationandcostsassociatedwithacuteischemicstroke